The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
AURA BIOSCIENCES INC COM 05153U107   23,863,152 3,039,892 SH   SOLE 1 3,039,892 0 0
CENTESSA PHARMACEUTICALS PLC SPONSORED ADS 152309100   225,583,674 19,963,157 SH   SOLE 1 19,963,157 0 0
PHATHOM PHARMACEUTICALS INC COM 71722W107   79,273,755 7,464,572 SH   SOLE 1 7,464,572 0 0
MERUS N V COM N5749R100   52,641,331 1,169,028 SH   SOLE 1 1,169,028 0 0
NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES N62509109   67,865,212 2,869,565 SH   SOLE 1 2,869,565 0 0